Hebrew University reveals gut stem cells mount active defense against Salmonella

For decades, scientists understood intestinal stem cells as the body's internal construction crew—cells that divide and rebuild the gut lining as it wears away. A new study from Hebrew University upends that narrow view. These cells, it turns out, are also sentries. They detect danger. They respond to it. They fight back.

The research, published this week in Nature Immunology, shows that when Salmonella bacteria breach the gut, stem cells don't simply sit and regenerate. Instead, they sense the infection directly and launch an immune response. The mechanism is elegant: stem cells detect the pathogen and activate what's called an inflammasome—a multiprotein complex that triggers a cascade of defensive actions. This happens fast, before the infection can take hold.

The team, led by PhD student Sacha Lebon under the supervision of Dr. Matan Hofree at Hebrew University and Dr. Moshe Biton at the Weizmann Institute, mapped this process in granular detail using single-cell RNA sequencing, genetic tracing, and laboratory models of intestinal tissue. What they found was a rapid transformation: when stem cells detect Salmonella enterica inside the gut, they differentiate into specialized cells called antimicrobial Paneth cells. These newly formed cells secrete molecules that make the environment hostile to bacteria, limiting how long the pathogen can survive and reproduce. It's a built-in defense mechanism that explains why most Salmonella infections—which typically cause gastrointestinal illness within 72 hours of exposure—resolve on their own within days without medical intervention.

Dr. Hofree framed the significance plainly: intestinal stem cells carry a dual responsibility. They rebuild tissue. They also stand guard. "Our findings show that intestinal stem cells are not only responsible for tissue regeneration, but also participate directly in the early defense against bacterial infection," he said. The study revealed that this protective program is intrinsic—hardwired into the cells themselves—and helps preserve intestinal function even while infection is underway.

But the implications extend beyond foodborne illness. The researchers discovered something unexpected: the same stem cell signature that activates during Salmonella infection appears enriched in the intestinal stem cells of patients with Crohn's disease, a chronic inflammatory bowel condition. This connection suggests that the epithelial defense pathways—the gut's first line of immune protection—may be linked to the dysregulation that characterizes inflammatory bowel disease. The finding opens a new angle for understanding why some people develop chronic intestinal inflammation and hints at potential therapeutic targets.

The work represents a shift in how scientists think about stem cells in the gut. They are not passive builders. They are active participants in immunity, capable of sensing threats and mounting coordinated responses. Understanding this dual role could reshape approaches to both acute infections and chronic intestinal diseases.